& Jorns, M

Before starting GLP-1 medications: Ensure you've had a recent diabetic eye screening (within the past 12 months) Discuss your retinopathy status with your prescribing clinician If you have known retinopathy, consider ophthalmology review before initiation Understand that gradual dose titration may help avoid very rapid changes in blood glucose, which is a general principle in diabetes management During treatment: Attend all scheduled diabetic eye screening appointments without fail If you have pre-existing retinopathy, your diabetes team may consider more frequent monitoring based on your individual clinical situation Control blood pressure to target levels (below 140/90 mmHg, or below 130/80 mmHg if you have kidney, eye or cerebrovascular damage, if tolerated) [13] Maintain good overall glycaemic control whilst avoiding excessively rapid HbA1c reductions when possible Stop smoking if applicable, as tobacco significantly worsens diabetic eye disease Manage cholesterol levels according to NICE guidance for cardiovascular risk reduction Communicate openly with your healthcare team about any visual symptoms, even if they seem minor

Its called Ozempic, one comment read, and many joined the statement, one even saying she has Ozempic face. Another social media user, who says she found help in GLP-1s herself, wanted Obama to disclose her possible use of the drugs
Care managers can centralize patient data, manage multiple conditions in a single platform, and facilitate quicker referrals or medication adjustments
Understanding the difference is key to building a routine that works
Liposomal and acetyl-glutathione formulations may offer better absorption than standard reduced glutathione, though clinical evidence for liver benefits remains limited